Elucid
Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.
$55MSeries D
ParticipantEM
Elevage Medical Technologies
Activity from announced rounds
Activity in this selectionimc-456dc02f
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $219.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionNervonik
Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions
$52.5MSeries B
Role not disclosedImperative Care
Develops treatments for patients suffering from thromboembolic disease
$100MGrowth
Role not disclosedNuclera
Provides rapid access to functional proteins through benchtop eProtein Discovery System
$12MSeries C+
Role not disclosed